- Home
- ROMA vs BIOA Comparison
ROMA vs BIOA Comparison
Compare ROMA & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROMA
- BIOA
- Stock Information
- Founded
- ROMA 2018
- BIOA 2015
- Country
- ROMA Hong Kong
- BIOA United States
- Employees
- ROMA N/A
- BIOA N/A
- Industry
- ROMA Savings Institutions
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- ROMA Finance
- BIOA Health Care
- Exchange
- ROMA Nasdaq
- BIOA Nasdaq
- Market Cap
- ROMA 150.7M
- BIOA 155.2M
- IPO Year
- ROMA 2024
- BIOA 2024
- Fundamental
- Price
- ROMA $3.31
- BIOA $4.90
- Analyst Decision
- ROMA
- BIOA Hold
- Analyst Count
- ROMA 0
- BIOA 4
- Target Price
- ROMA N/A
- BIOA $5.67
- AVG Volume (30 Days)
- ROMA 47.5K
- BIOA 177.6K
- Earning Date
- ROMA 09-25-2025
- BIOA 11-06-2025
- Dividend Yield
- ROMA N/A
- BIOA N/A
- EPS Growth
- ROMA N/A
- BIOA N/A
- EPS
- ROMA N/A
- BIOA N/A
- Revenue
- ROMA $1,568,345.00
- BIOA $3,863,000.00
- Revenue This Year
- ROMA N/A
- BIOA N/A
- Revenue Next Year
- ROMA N/A
- BIOA N/A
- P/E Ratio
- ROMA N/A
- BIOA N/A
- Revenue Growth
- ROMA 23.21
- BIOA N/A
- 52 Week Low
- ROMA $0.54
- BIOA $2.88
- 52 Week High
- ROMA $4.66
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- ROMA 54.30
- BIOA 56.85
- Support Level
- ROMA N/A
- BIOA $4.55
- Resistance Level
- ROMA $3.40
- BIOA $5.09
- Average True Range (ATR)
- ROMA 0.33
- BIOA 0.23
- MACD
- ROMA 0.01
- BIOA 0.00
- Stochastic Oscillator
- ROMA 97.38
- BIOA 63.64
About ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.